SCHEMBL7987442

SCHEMBL7987442

CCc1nc2ncn(Cc3cc(C)c(OCc4ccccc4)c(C)c3)c2c(=O)[nH]1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 4/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ GAA P10253 1/20 0.39
▸ HTT P42858 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.38
▸ XBP1 P17861 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ HCAR2 Q8TDS4 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ TNKS2 Q9H2K2 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7992335 0.88 HPGD (0.44) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7975251 0.85 SMN1; SMN2 (0.60) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7987778 0.85 ALDH1A1 (0.51) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7987444 0.84 PARN (0.42) HPGDALDH1A1SMN1; SMN2KMT2AHTT
SCHEMBL7987957 0.81 HPGD (0.43) HPGDALDH1A1SMN1; SMN2KMT2ABRD4
SCHEMBL7984374 0.81 HPGD (0.43) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7974255 0.80 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7973932 0.79 SMN1; SMN2 (0.53) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7985648 0.78 HPGD (0.47) HPGDALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL7987443 0.78 GAA (0.37) HPGDALDH1A1SMN1; SMN2KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 — — US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 — — EP disclosed
Send feedback